IRADIMED CORPORATION Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
IRADIMED CORPORATION (IRMD) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $227.98 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-09-03.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-09-03
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was -$1.00.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $1.00.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $2.00.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $227.98K.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $227.98K.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $27.71K.
- IRADIMED CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $3.18M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $0.00 derived: sum of 2 quarters · filed 2025-09-03 | $2.00 derived: sum of 3 quarters · filed 2025-09-03 | $227.98K 10-K/A · filed 2025-09-03 |
| 2023-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.00 derived: sum of 2 quarters · filed 2024-10-31 | $227.98K 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $2.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $227.98K 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | $227.98K 10-Q · filed 2024-05-02 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $27.71K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $27.71K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $27.71K 10-Q · filed 2022-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $0.00 derived: sum of 2 quarters · filed 2022-03-04 | $0.00 derived: sum of 3 quarters · filed 2022-03-04 | $3.18M 10-K · filed 2022-03-04 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $3.18M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.18M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $3.18M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |